Point72 Asset Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Point72 Asset Management’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-168,703	Closed	-$420K	–	1297
2018 Q4	$420K	Hold	168,703	–	–	﹤0.01%	879
2018 Q3	$1.23M	Sell	168,703 -45,297	-21%	-$198K	0.01%	827
2018 Q2	$792K	Buy	214,000 +34,000	+19%	+$157K	﹤0.01%	851
2018 Q1	$693K	Buy	+180,000	New	+$757K	﹤0.01%	841
2016 Q2	–	Sell	-76,659	Closed	-$1.07M	–	914
2016 Q1	$1.07M	Sell	76,659 -642,441	-89%	-$9.42M	0.01%	616
2015 Q4	$14.7M	Sell	719,100 -280,900	-28%	-$4.33M	0.12%	204
2015 Q3	$13.1M	Buy	1,000,000 +35,886	+4%	+$595K	0.1%	255
2015 Q2	$14.8M	Sell	964,114 -67,886	-7%	-$1.3M	0.1%	257
2015 Q1	$20.6M	Buy	1,032,000 +53,520	+5%	+$1.2M	0.14%	199
2014 Q4	$20.6M	Buy	978,480 +491,875	+101%	+$10M	0.14%	209
2014 Q3	$9.06M	Buy	+486,605	New	+$8.81M	0.07%	298

Other funds holding AGTC

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Point72 Asset Management's AGTC Position: Q1 2019 in Review

Point72 Asset Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2019, closing a stake of 168,703 shares — an estimated $420K sold.

Point72 Asset Management first reported a position in AGTC in Q3 2014 and held it in 11 quarters. The position peaked at $20.6M in Q1 2015. 50 funds tracked by Wall St. Rank hold AGTC as of Q1 2019.

Point72 Asset Management reported no remaining Applied Genetic Technologies Corporation position as of Q1 2019 after selling out during the quarter.
Point72 Asset Management sold 168,703 Applied Genetic Technologies Corporation shares in Q1 2019, an estimated $420K.
Point72 Asset Management first reported a position in Applied Genetic Technologies Corporation in Q3 2014 and held it in 11 quarters.
Point72 Asset Management's Applied Genetic Technologies Corporation position peaked at $20.6M in Q1 2015.
50 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2019.

Based on Point72 Asset Management's 13F filing for Q1 2019, filed 15 May 2019.